Check the time stamp on this data. Updated AI-Generated Signals for Pulmonx Corporation (LUNG) available here: LUNG.

Immune checkpoint inhibitors (ICIs) redefined the therapeutics of non-small cell lung cancer (NSCLC), leading to significant survival benefits and unprecedented durable responses. However, the ...

Sep. 22, 2023 — A novel drug target has been newly identified in the fight against drug resistance in cancer ... Small Cell Lung Cancer: New Approach to Overcoming Chemo-Resistance Sep.

A recent report by the Indian Council of Medical Research (ICMR) said that diseases like urinary tract infections (UTIs), ...

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) reported initial Phase 2 data of BDTX-1535. The data demonstrated encouraging ...

The inhibition of ERK5 is a potential complementary strategy for countering FAK inhibitor resistance in patients with lung ...

Patients with pulmonary arterial hypertension who received bilateral lung or heart-lung transplants showed similar survival ...

The study used data from 10 ... Diabetes Drug Reduces Drug Resistance in Lung Cancer, Improving Chemotherapy Effectiveness July 17, 2024 — A medication used to treat diabetic neuropathy may make ...

In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d ...

Under an in-license agreement worth up to $294 million, Roivant Sciences gains exclusive worldwide rights from Bayer to ...

Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...